The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary


Apr 12, 2014

I just had sex with woman, i really worry about HIV, after I had 2 hours, I use ricovir-em so is that can help me from HIV? So what if I don't have HIV can I use that?

Response from Dr. Young


You can take medications after possible exposure to substantially lower the risk of HIV infection-- this is called post-exposure prophylaxis or PEP. Ricovir-EM is a two drug generic combo of tenofovir and emtricitabine (we call this Truvada here in the US) and is commonly part of a three drug regimen used for PEP. Some agencies use Truvada alone for PEP. PEP should be administered by a medical provider who first tests for HIV, since it's important to establish this before starting on meds (especially a two drug regimen); PEP should be started within 72 hours of exposure and taken for 28 days to be effective.

This entire category is devoted to questions about PEP, and I'd encourage you (and readers) to scan for questions and answers.


truvada vs tenvir-em
can you help me?

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint